Medical Device Reprocessing Market Report 2026

The medical device reprocessing market size has grown rapidly in recent years. It will grow from $2.78 billion in 2025 to $3.22 billion in 2026 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to rising healthcare operational costs, early adoption of reusable surgical instruments, hospital initiatives to reduce medical waste, regulatory approvals for reprocessed devices, increased demand for sterilization services.

The medical device reprocessing market size is expected to see rapid growth in the next few years. It will grow to $5.91 billion in 2030 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to growth in sustainable healthcare practices, expansion of outpatient and ambulatory centers, increasing regulatory clarity for reprocessed devices, rising demand for affordable medical procedures, technological improvements in sterilization and validation processes. Major trends in the forecast period include growing adoption of reusable medical devices, increasing emphasis on cost reduction in hospitals, rising focus on infection control and patient safety, expansion of third-party reprocessing service providers, standardization of reprocessing protocols and quality assurance.

An increase in surgical procedures is anticipated to drive the growth of the medical device reprocessing market in the coming years. Surgical procedures involve medical treatment that requires making an incision and using instruments to treat or repair disease within the body. Reprocessing entails the removal of blood, tissue, and other biological residues from equipment and the inactivation of infectious microorganisms to ensure that it is safe and hygienic for the next patient. For example, in June 2024, the American Society of Plastic Surgeons, a US-based non-profit organization, reported that minimally invasive procedures grew by 7 percent in 2023, surpassing the overall growth rate of surgical procedures by 2 percent. Consequently, the rise in surgical procedures is fueling the expansion of the medical device reprocessing market.

Major companies operating in the medical device reprocessing market are focusing on technological advancement, such as GI endoscopes compatible with hydrogen peroxide gas plasma sterilization to reduce cross-contamination and enhance patient safety. GI endoscopes compatible with hydrogen peroxide gas plasma sterilization refers to endoscopes designed to withstand sterilization using hydrogen peroxide vapor and low-temperature plasma, ensuring elimination of bacteria, viruses, and spores. For instance, in August 2024, Pentax Medical, a Japan-based medical device company, in collaboration with Advanced Sterilization Products (ASP), a US-based sterilization solutions company, received U.S. Food and Drug Administration (FDA) clearance for a duodenoscope with new sterilization technology. The device features redesigned distal ends and detachable components for thorough cleaning, allowing sterilization to reach hard-to-clean areas and reducing microbial retention. Its unique design ensures compatibility with high-level disinfectants and compliance with updated FDA reprocessing guidelines. Intended for ERCP procedures in hospitals and clinics, it enhances patient safety, lowers infection risk, and streamlines the reprocessing workflow.

In October 2023, Getinge AB, a medical technology company based in Sweden, acquired Healthmark Industries Co. Inc. for an undisclosed sum. With this acquisition, Getinge AB intends to strengthen its infection control portfolio by incorporating Healthmark’s expertise in innovative cleaning and packaging solutions for healthcare providers. Healthmark Industries is a US-based firm that focuses on developing and manufacturing products for the cleaning, testing, and validation of medical devices.

Major companies operating in the medical device reprocessing market are Cardinal Health, Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic PLC, Danaher Corporation, Fresenius Medical Care, Medline Industries Inc., Stryker Corporation, GE Healthcare, Boston Scientific, Fujifilm Medical Systems, Zimmer Biomet, Olympus Corporation, Intuitive Surgical, Hologic, STERIS Healthcare, Getinge AB, Teleflex Inc., Centurion Medical Inc., Vanguard AG, SteriPro, Medivators Inc., Hygia Healthcare LLC, Innovative Health, LUMITOS AG, SureTek Medical, 3M Health Care, ArjoHuntleigh, Northeast Scientific.

North America was the largest region in the medical device reprocessing market in 2025. Europe is expected to be the fastest-growing region in the medical device reprocessing market report during the forecast period. The regions covered in the medical device reprocessing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical device reprocessing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs affect the medical device reprocessing market by increasing the cost of imported reprocessing equipment, sterilization systems, and replacement components. Hospitals and reprocessing service providers in north america, europe, and parts of asia-pacific are most impacted due to reliance on international suppliers. Higher costs may slow infrastructure upgrades for smaller facilities. However, tariffs also support local manufacturing of reprocessing equipment and encourage regional service expansion, strengthening domestic reprocessing capabilities.

The medical device reprocessing market research report is one of a series of new reports that provides medical device reprocessing market statistics, including medical device reprocessing industry global market size, regional shares, competitors with a medical device reprocessing market share, detailed medical device reprocessing market segments, market trends and opportunities, and any further data you may need to thrive in the medical device reprocessing industry. This medical device reprocessing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical device reprocessing is a procedure carried out on used and reusable medical devices to enable their safe use on subsequent patients. This process is generally conducted by specialized healthcare facilities or companies that have the necessary equipment, expertise, and protocols to ensure proper cleaning and sterilization of the devices.

The primary categories of medical device reprocessing include reprocessing support and services and reprocessing of medical devices. Reprocessing support and services encompass the assistance and resources provided to healthcare facilities or companies engaged in medical device reprocessing. The main types of device categories involved are critical devices, semi-critical devices, and non-critical devices, which find applications in areas such as cardiology, gastroenterology, gynecology, orthopedics, general surgery, and more. These devices are utilized by various end-users, including hospitals, ambulatory service centers, and home healthcare providers.

The medical device reprocessing market consists of revenues earned by entities by providing sterilizing, and disinfecting, as well as evaluation and restoration of the used devices. The market value includes the value of related goods sold by the service provider or included within the service offering. The medical device reprocessing market also includes sales of surgical forceps, endoscopes, stethoscopes, catheters, and laryngoscopes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.